Your browser doesn't support javascript.
loading
Metabolomic Association and Risk Prediction With Heart Failure in Older Adults.
Liu, Guning; Nguyen, Ngoc Quynh H; Wong, Kari E; Agarwal, Sunil K; Boerwinkle, Eric; Chang, Patricia P; Claggett, Brian L; Loehr, Laura R; Ma, Jianzhong; Matsushita, Kunihiro; Rodriguez, Carlos J; Rossi, Joseph S; Russell, Stuart D; Stacey, R Brandon; Shah, Amil M; Yu, Bing.
Afiliação
  • Liu G; Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
  • Nguyen NQH; Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
  • Wong KE; Metabolon Inc, Research Triangle Park, Morrisville, NC (K.E.W.).
  • Agarwal SK; Interventional Cardiology at St. John's Hospital, Hospital Sister Health System, Springfield, IL (S.K.A.).
  • Boerwinkle E; Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
  • Chang PP; Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill (P.P.C., J.S.R.).
  • Claggett BL; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA (B.L.C.).
  • Loehr LR; Department of Medicine, University of North Carolina, Chapel Hill (L.R.L.).
  • Ma J; Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
  • Matsushita K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).
  • Rodriguez CJ; Department of Medicine, Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.J.R.).
  • Rossi JS; Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill (P.P.C., J.S.R.).
  • Russell SD; Department of Medicine, Duke University School of Medicine, Durham, NC (S.D.R.).
  • Stacey RB; Department of Cardiology, Wake Forest School of Medicine, Winston-Salem, NC (R.B.S.).
  • Shah AM; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (A.M.S.).
  • Yu B; Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
Circ Heart Fail ; 17(3): e010896, 2024 03.
Article em En | MEDLINE | ID: mdl-38426319
ABSTRACT

BACKGROUND:

Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF pathogenesis and improve at-risk population identification. This study aimed to identify metabolites associated with incident HF, HFpEF, and HF with reduced ejection fraction and examine risk prediction in older adults.

METHODS:

Untargeted metabolomic profiling was performed in Black and White adults from the ARIC study (Atherosclerosis Risk in Communities) visit 5 (n=3719; mean age, 75 years). We applied Cox regressions to identify metabolites associated with incident HF and its subtypes. The metabolite risk score (MRS) was constructed and examined for associations with HF, echocardiographic measures, and HF risk prediction. Independent samples from visit 3 (n=1929; mean age, 58 years) were used for replication.

RESULTS:

Sixty metabolites (hazard ratios range, 0.79-1.49; false discovery rate, <0.05) were associated with incident HF after adjusting for clinical risk factors, eGFR, and NT-proBNP (N-terminal pro-B-type natriuretic peptide). Mannonate, a hydroxy acid, was replicated (hazard ratio, 1.36 [95% CI, 1.19-1.56]) with full adjustments. MRS was associated with an 80% increased risk of HF per SD increment, and the highest MRS quartile had 8.7× the risk of developing HFpEF than the lowest quartile. High MRS was also associated with unfavorable values of cardiac structure and function. Adding MRS over clinical risk factors and NT-proBNP improved 5-year HF risk prediction C statistics from 0.817 to 0.850 (∆C, 0.033 [95% CI, 0.017-0.047]). The association between MRS and incident HF was replicated after accounting for clinical risk factors (P<0.05).

CONCLUSIONS:

Novel metabolites associated with HF risk were identified, elucidating disease pathways, specifically HFpEF. An MRS was associated with HF risk and improved 5-year risk prediction in older adults, which may assist at at-risk population identification.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Limite: Aged / Humans / Middle aged Idioma: En Revista: Circ Heart Fail Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Limite: Aged / Humans / Middle aged Idioma: En Revista: Circ Heart Fail Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article